GGrantIndex
Sort

35,931 grants matching parkinsons

Oscillations and Resonance in Basal Ganglia Circuits

$661,500
Charles J Wilson · University Of Texas San Antonio · R35 · FY2021 · NS

Oscillations and Resonance in Basal Ganglia Circuits

$661,500
Charles J Wilson · University Of Texas San Antonio · R35 · FY2023 · NS

Oscillations and Resonance in Basal Ganglia Circuits

$661,500
Charles J Wilson · University Of Texas San Antonio · R35 · FY2022 · NS

Oscillations and Resonance in Basal Ganglia Circuits

$661,500
Charles J Wilson · University Of Texas San Antonio · R35 · FY2019 · NS

Oscillations and Resonance in Basal Ganglia Circuits

$661,500
Charles J Wilson · University Of Texas San Antonio · R35 · FY2018 · NS

RNA-binding Factors Controlling Neurogenesis and Neurodegeneration

$661,436
Myriam Gorospe · National Institute On Aging · ZIA · FY2015 · AG

Neuromodulation of Brain States

$661,266
Liqun Luo · Stanford University · R01 · FY2018 · NS

Identifying Drugs to Treat Age-Dependent Neurodegeneration

$661,262
Kim D. Finley · Expression Drug Designs, Llc · R44 · FY2011 · AG

Exploiting Dopamine Receptor Functional Selectivity as an Approach to Treat Parkinson's Symptoms

$661,206
Marc G. Caron · Duke University · R01 · FY2017 · NS

In vivo synaptic and dopamine transporter imaging in Parkinson's disease

$660,955
David A Matuskey · Yale University · R01 · FY2025 · NS

Uncovering the functions of circRNAs in aging

$660,908
Sebastian Kadener · Brandeis University · R01 · FY2025 · AG

Temporal Patterns of Deep Brain Stimulation

$660,715
Warren M. Grill · Duke University · R37 · FY2021 · NS

Temporal Patterns of Deep Brain Stimulation

$660,715
Warren M. Grill · Duke University · R37 · FY2019 · NS

Temporal Patterns of Deep Brain Stimulation

$660,715
Warren M. Grill · Duke University · R37 · FY2020 · NS

Human iPSC-based personalized cell therapy of PD

$660,673
Kwang-Soo Kim · Mclean Hospital · R01 · FY2016 · NS

Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection

$660,642
Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2024 · AI

KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions

$660,531
Emmanuel J Mignot · Stanford University · U01 · FY2020 · NS

Biomarker Discovery and Validation in Parkinson's Disease

$660,444
Ted M. Dawson · Johns Hopkins University · U01 · FY2017 · NS

Next-generation antisense therapeutics for ALS and frontotemporal dementia

$660,421
Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · NS

Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension

$660,375
Italo Biaggioni · Vanderbilt University Medical Center · R01 · FY2024 · HL

Dual Mechanisms of Cognitive Control

$660,316
Todd Braver · Washington University · R37 · FY2020 · MH

Glial Involvement in REDOX Homeostasis in the Substantia Nigra

$660,181
Rita Marie Cowell · Southern Research Institute · R01 · FY2022 · NS

Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease

$660,048
Jeffrey M Friedman · Rockefeller University · R01 · FY2020 · NS

Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling

$660,007
Bindu Paul · Johns Hopkins University · R01 · FY2025 · AG

How LC Integrity in Older Adults Mediates Perceptual and Memory Processes

$659,912
Xiaoping P Hu · University Of California Riverside · R01 · FY2024 · AG